Lucienne Ide, M.D., Ph.D., a healthcare innovator and CEO of Rimidi Diabetes, Inc., brings her diverse experiences in medicine, science, venture capital and technology to transforming the delivery of chronic care management. Rimidi’s cloud-based diabetes management platform provides a comprehensive solution for healthcare systems that connects healthcare providers with their patients. Rimidi enables providers to receive a clear snapshot of each patient’s diabetes numbers and unique needs by merging patient and clinical data and provides them with decision support tools to make individualized treatment decisions. Rimidi has been named a Top 5 Company to Watch by the Georgia Pharmacists Association and a Top 10 Innovative Company in Georgia by the Technology Association of Georgia. Rimidi also is an ATDC Select Company. Additionally, the company received a “Platinum” ranking by BAnalytics as a socially conscious company.
Follow Rimidi on Facebook, LinkedIn and Twitter.
As a young Syrian Kurdish refugee washing dishes in a restaurant to support his family, Heval Kelli could not know that many years later he would be a distinguished fellow in cardiology at a university less than one mile from where his journey in the United States began. Dr. Kelli’s research focuses on utilizing mobile health technologies to bring health education to underserved areas. In collaboration with his lifelong mentor Dr. Omar Lattouf, he has launched a global initiative to combat cardio metabolic syndrome through hosting seminars in the United States and around the globe. Dr. Kelli is launching a mobile application that allows patient self-risk stratification for cardiovascular diseases. He is the co-editor of Complex Cardiac, an on-line cardiac textbook, co-editor of an on-line live webinar channel TEDNETS, where speakers give live interactive lectures to learners around the globe. He currently serves on the Board of Advisors at Rimidi.
Learn more about Dr. Heval Kelli on his website.
